Skip to content
Skip to navigation
Skip to footer

Archive

View global media contacts

Home / Media Centre / Archive

Here you can find the archive of all Press Releases prior to 2023

Filter by date:

Select year

Select month

Showing 1262 press releases before 2023

Enhertu achieved a tumour response rate of 45.3% in patients with HER2-positive metastatic colorectal cancer in Phase II DESTINY-CRC01 trial
29 May 2020
Imfinzi plus tremelimumab demonstrated promising clinical activity and tolerability in patients with advanced liver cancer
29 May 2020
Tagrisso demonstrated unprecedented disease-free survival in the adjuvant treatment of Stage IB-IIIA patients with EGFR-mutated lung cancer
28 May 2020
AstraZeneca collaborates with ArcherDX to use personalised cancer assays to detect minimal residual disease in lung cancer trials
26 May 2020
Enhertu granted Orphan Drug Designation in the US for gastric cancer
22 May 2020
AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
21 May 2020
Lynparza approved in the US for HRR gene-mutated metastatic castration-resistant prostate cancer
20 May 2020
Enhertu granted Breakthrough Therapy Designation in the US for HER2-mutant metastatic non-small cell lung cancer
18 May 2020
Bevespi Aerosphere approved in China for patients with COPD
18 May 2020
AstraZeneca responds to public comments made about the globalisation of our collaboration with the University of Oxford on a potential COVID-19 vaccine
15 May 2020

<
33
34
35
36
37
38
39
126
>

All of our latest press releases and articles are available to explore

Use a maximum of two downloads here

Explore